No Data
Meilan Medical (688273.SH): The rehabilitation sports product line has applied the relevant technology of hand function rehabilitation robot in the diagnostic and treatment system on sale.
On November 15, Gelonghui reported that Mairande (688273.SH) stated on the interactive platform that the company's sports rehabilitation product line has applied the relevant technology of hand function rehabilitation siasun robot&automation in the treatment systems currently on sale, including the finger joint rehabilitation assessment system and the portable hand function rehabilitation assessment system; these mainly target the assessment and rehabilitation of motor dysfunction and hand function in populations suffering from cerebral palsy and post-stroke, and have been utilized in departments such as rehabilitation, pediatric rehabilitation, orthopedics, and geriatrics.
Meilande (688273): In Q3 2024, the income growth is stable, and the high growth of reproductive anti-aging continues.
The company released the third quarter report of 2024. In the first three quarters of 2024, the company achieved revenue of 0.331 billion (yoy +13.81%), net income attributable to equity holders was 0.096 billion yuan (yoy +13.37%), net profit after deduction of non-recurring gains and losses.
MEILAND: THIRD QUARTERLY REPORT 2024
Third Quarter Report 2024
Meilland (688273.SH) released its performance for the first three quarters, with a net income of 96.0706 million yuan, a year-on-year growth of 13.37%.
Meilande (688273.SH) released the quarterly report for the first three quarters of 2024, and the company achieved revenue of 3...
Mai Lande (688273.SH): The net income for the first three quarters was approximately 96.07 million yuan, a year-on-year increase of 13.37%.
Gelonghui October 28th news: Mai Lande (688273.SH) announced that the revenue in the first three quarters of 2024 was approximately 0.331 billion yuan, a year-on-year increase of 13.81%; the net income attributable to shareholders of the listed company was approximately 96.07 million yuan, a year-on-year increase of 13.37%; and the basic earnings per share was 0.9728 yuan.
No Data
No Data